In this study, PRMT5 protected NSCLC cells from caspase activation and apoptosis induced by anti-cancer drugs, and knocking down its expression led to CFLAR downregulation and activating chemotherapeutic-induced apoptosis. This evidence concerns the gene PRMT5 and non-small cell lung carcinoma.